Cardiology News and Research

Latest Cardiology News and Research

Study increases likelihood that MRI could be used as predictive technology to determine which patients should be placed on statin therapy for atherosclerosis

Using modified magnetic resonance imaging (MRI) techniques, researchers at Johns Hopkins have been able to detect the early benefits of a cholesterol-lowering medication much sooner than before.

11 Oct 2004

Signaling pathway could be a valuable target for future drug therapies against systemic lupus erythematosus

Medical investigators at the Hospital for Special Surgery have identified an important new signaling pathway they believe could be a valuable target for scientists to aim at with future drug therapies that might one day reverse diseases such as systemic lupus erythematosus, according to a recent article published in “Nature Immunology.”

11 Oct 2004

Folate can help women reduce their risk of developing high blood pressure

Young women who consume more than 800 micrograms (ug) of folate per day can reduce their risk of developing high blood pressure by almost a third compared to those who consume less than 200 ug/day, according to new research presented at the American Heart Association's 58th Annual High Blood Pressure Research Conference.

11 Oct 2004

Atheromatosis, which lies behind heart attacks, stroke, and other cardiovascular problems, has a major impact on public health

These two diseases are completely different from each other, but they do have one common denominator: inflammation. Researchers at Lund University in Sweden can now show that it might also be possible to treat them with the same drug.

10 Oct 2004

Low-dose estrogen therapy significantly reduced the progression of fatty buildup in the arteries leading to the heart

“We’ve shown that you can get the same reduction in coronary artery atherosclerosis with standard-dose or low-dose estrogen,” said Thomas B. Clarkson, D.V.M., one of the investigators. “It is very significant.”

10 Oct 2004

Progestin in hormone therapy could dramatically affect heart attack severity

“One type of hormone therapy limited heart muscle damage to only 5 percent while another resulted in permanent damage to 35 percent of muscle,” said J. Koudy Williams, Ph.D., lead investigator, from Wake Forest Baptist. “If we can learn more about this mechanism we might be able to identify better hormone therapies for postmenopausal women.”

10 Oct 2004

Diet high in soy could be good for the hearts and bones of premenopausal women

The results suggest that for cholesterol and bone density, the natural plant estrogens in soy may be most effective in conjunction with the body’s own estrogen – which would make it especially potent in women who haven’t reached menopause. They also point to the possibility the estrogen-soy synergy could have other benefits as well.

10 Oct 2004

Surgery for extremely obese patients may be more effective for weight reduction

A new report issued today by HHS’ Agency for Healthcare Research and Quality concludes that surgery for extremely obese patients who have tried and failed to lose weight with exercise and diet may be more effective for weight reduction.

10 Oct 2004

Walking fast after stroke improves rehabilitation

Stroke survivors who walked fast in a rehabilitation program improved their overall walking ability, according to a small study reported in Stroke: Journal of the American Heart Association.

8 Oct 2004

Research shows C. botulinum uses SONO to detect nitric oxide

A deadly bacterium's defense against a mortal molecular enemy illuminates the origins and structure of a vital protein involved in human cell signaling, University of Texas Medical School scientists report in Science Express.

8 Oct 2004

Aspirin might well be considered the top utility player in the medicine cabinet

This cheap over-the-counter drug can be used not only for fever, pain and arthritis, but to prevent heart attack, stroke or angina. It also may reduce the risk of colorectal cancer. Yet aspirin also has side effects worth considering, and its very accessibility may hamper its use.

8 Oct 2004

Child heart deaths at Bristol fall below national average

Child heart deaths at the Bristol Royal Infirmary have fallen markedly, to below the national average, finds a study in this week's BMJ.

8 Oct 2004

Vioxx: an unequal partnership between safety and efficacy

Last week’s dramatic withdrawal of the COX-2 inhibitor rofecoxib (Vioxx) is discussed in this week’s lead editorial in THE LANCET, which comments that more vigilant drug licensing is vital to prevent the endangering of patients’ health.

7 Oct 2004

Children who have problems breathing during sleep tend to score lower on tests of mental development and intelligence

Children who have problems breathing during sleep tend to score lower on tests of mental development and intelligence than do other children their age, according to two studies funded by the National Institutes of Health (NIH). Both studies appear in the October issue of Journal of Pediatrics.

7 Oct 2004

Canadian Rheumatology Association issues statement on Vioxx alternatives

The Canadian Rheumatology Association (CRA) has issued a statement to its 350 members and other interested parties, recommending alternative treatment considerations in the wake of the worldwide recall of Merck's rofecoxib, (Vioxx(R)) last week.

7 Oct 2004

Short-term exercise has a significant impact on insulin action in overweight people

Carefully controlling the amount of food and drink that formerly sedentary, overweight people ingest during and after short-term exercise has a significant impact on insulin action.

7 Oct 2004

Statistics reveal that there are now 1.8 million people with diabetes in the UK

New statistics revealed by Diabetes UK show that there are now 1.8 million people with diabetes in the UK – three per cent of the population, equivalent to the combined population of Liverpool, Birmingham and Manchester.

7 Oct 2004

Lipid profile differences explain why two people with the same overall cholesterol level can have different degrees of cardiovascular disease

When it comes to lipid profiles -- a key measure of heart disease risk-- it appears that African-Americans and women have it better than whites and men, according to a new study by Duke University Medical Center researchers.

7 Oct 2004

Breast cancer drug Taxotere extends life of prostate cancer patients

Men with androgen-independent (hormone-refractory) metastatic prostate cancer treated with the breast-cancer drug Taxotere (docetaxel) Injection Concentrate in combination with the drug estramustine survived 20 percent longer than similar patients receiving the standard therapy

6 Oct 2004

Transatlantic study to help damaged hearts repair themselves

A $6 million, five-year grant from the Parisian Fondation Leduq has set up a transatlantic effort to study ways to help damaged hearts repair themselves, using stem cells from bone marrow, bloodstream, and adult heart tissue.

6 Oct 2004